Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/793524/000149315220003807/form10-k.htm
June 2022
June 2021
January 2021
December 2020
August 2020
August 2020
July 2020
June 2020
April 2020
January 2020
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2019 | Mar. 12, 2020 | Jun. 30, 2019 | |
Document and Entity Information [Abstract] | |||
Entity Registrant Name | RESEARCH FRONTIERS INC | ||
Entity Central Index Key | 0000793524 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2019 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity a Well-known Seasoned Issuer | No | ||
Entity a Voluntary Filer | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business Flag | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 79,350,170 | ||
Entity Common Stock, Shares Outstanding | 31,411,107 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2019 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/793524/000149315220003807/form10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Research Frontiers Inc.
Research Frontiers Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Rating
Learn More![]()
Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the contract period as these performance obligations are satisfied.
The Company expects to use its cash to fund its research and development of SPD light valves, its expanded marketing initiatives, and for other working capital purposes.
In addition, the Company incurred higher bad debt expenses ($114,000), higher investor relations and marketing costs, net of non-cash consultant charges discussed above, ($78,000) and higher professional fees ($91,000).
During 2019, the Company's cash and cash equivalents balance increased by $3,622,544 principally as a result of cash proceeds of $5,770,545 from the sale of common stock and warrants and the exercise of options and warrants, partially offset by cash used for operations of $2,082,719 and cash used for the purchase of property and equipment of $65,282.
During 2018, the Company's cash and cash equivalents balance increased by $1,231,569 principally as a result of cash proceeds of $3,314,292 from the sale of common stock and warrants and the exercise of options and warrants, partially offset by cash used for operations of $2,071,060 and cash used for the purchase of property and equipment of $11,663.
Based on the royalty rate...Read more
The difference was primarily due...Read more
The Company expects to generate...Read more
Production efficiencies are expected to...Read more
Operating expenses increased by $634,280...Read more
The Company determined that its...Read more
Because the Company's license agreements...Read more
Eventual success of the Company...Read more
The Company's working capital and...Read more
There can be no assurances...Read more
In addition to these macro...Read more
The increase was the result...Read more
The Company operates in a...Read more
When operations from the Company's...Read more
An entity need not reassess...Read more
As permitted, the Company did...Read more
No income tax benefit or...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Research Frontiers Inc provided additional information to their SEC Filing as exhibits
Ticker: REFR
CIK: 793524
Form Type: 10-K Annual Report
Accession Number: 0001493152-20-003807
Submitted to the SEC: Thu Mar 12 2020 4:01:46 PM EST
Accepted by the SEC: Thu Mar 12 2020
Period: Tuesday, December 31, 2019
Industry: Patent Owners And Lessors